Professor Warwick Anderson

Professor Warwick Anderson is the Secretary General of the International Human Frontier Science Program Organization. Supported by 14 leading scientific research countries and the EU. HFSPO funds international cooperation in frontier, transformative research in the life sciences.

Professor Anderson graduated a B. Sc. (Hons) from the University of New England after matriculating from Maclean High School, NSW. He obtained his Ph. D. from the University of Adelaide and had research positions at the Harvard Medical School, University of Sydney and Baker Medical Research Institute.  His academic appointments included (the inaugural) Head of the School of Biomedical Sciences and Professor of Physiology at Monash University and he was an elected Professorial Representative on Monash University Councill.

Professor Anderson was the first Chief Executive Officer of the National Health and Medical Research Council of Australia (2006-2015) following its establishment as an independent statutory agency.  Professor Anderson renewed NHMRC’s peer review processes, established funding vehicles to support newly developing research fields and reformed NHMRC’s health guidelines processes. He established an Australian ethical framework for responsible conduct in research, developed a number of initiatives essential to Australia’s health reform agenda and committed substantial NHMRC research funding to improving Aboriginal health.

He also greatly expanded NHMRC’s international research support including through the Global Alliance for Chronic Disease and the International Cancer Genome Consortium and established bilateral research funding agreements with the National Medical Research Council of Singapore, National Natural Science Foundation of China, the New Zealand Health Research Council, the Canadian Institutes of Health Research and the Californian Institute of Regenerative Medicine.

NHMRC funding doubled during Professor Anderson’s tenure.

He has been a member of the Prime Minister’s Science, Engineering and Innovation Council (Gillard Government), Cooperative Research Centres Committee, Australian Research Committee, Strengthened Export Controls Steering Group of the Department of Defence, National Collaborative Research Infrastructure Committee, National Research Infrastructure Council, Coordinating Committee on Innovation and the Australian Public Service 200.

He is currently a Emeritus Professor at Monash University, a member of the Singapore Health and Biomedical Sciences International Advisory Council, the International Advisory Board of the Australasian Society for HIV Medicine, the Presidential Visiting Committee of the Dana Farber Cancer Institute, and the Hudson Institute of Medical Research Board of Governance.

He holds honorary doctorates from the University of Adelaide and University of Newcastle.

He is an Honorary Fellow of the Royal College of Pathologists of Australasia, Honorary Fellow of the Australian Academy of Health and Medical Science and an International Fellow of the American Heart Foundation.

He is currently leading an International coalition to achieve sustainable equitable funding for essential data resources in life and biomedical sciences.

His research has focussed on cardiovascular and renal physiology, including morphometric, endocrinological, neural and functional aspects of the kidney and its vasculature. His group has made significant contributions to the role of renal mechanisms in the regulation of arterial blood pressure, including major findings on the cascade of mechanisms that lead to hypertension from renal artery disease (including fluid modelling studies), the role of renal innervation in renal function and blood pressure control, renal oxygenation, and remodelling of the intra-renal vascular in hypertension.

He has published over 170 peer review articles and supervised 13 student to a Ph.D.

He has published extensively on research policy issues.

He was made a Member of the Order of Australia in 2005.